articleJournal of the American Chemical SocietyJul 25, 2014Closed access

Activatable Fluorescence/MRI Bimodal Platform for Tumor Cell Imaging via MnO 2 Nanosheet–Aptamer Nanoprobe

Hunan University · Xiangya Hospital Central South University · +1 more institution

PubMed
Indexed incrossrefpubmed

Abstract

A novel dual-activatable fluorescence/MRI bimodal platform is designed for tumor cell imaging by using a redoxable manganese dioxide (MnO2) nanosheet-aptamer nanoprobe. The redoxable MnO2 nanosheet acts as a DNA nanocarrier, fluorescence quencher, and intracellular glutathione (GSH)-activated MRI contrast agent. In the absence of target cells, neither fluorescence signaling nor MRI contrast of the nanoprobe is activated. In the presence of target cells, the binding of aptamers to their targets weakens the adsorption of aptamers on the MnO2 nanosheets, causing partial fluorescence recovery, illuminating the target cells, and also facilitating the endocytosis of nanoprobes into target cells. After endocytosis,…

Citation impact

579
total citations
FWCI
20.77
Percentile
100%
References
37
Citations per year

Authors

8

Topics & keywords

Keywords
  • Nanoprobe
  • Chemistry
  • Nanosheet
  • Aptamer
  • Fluorescence
  • Fluorescence-lifetime imaging microscopy
  • Nanotechnology
  • Nuclear magnetic resonance
No related works found for this paper.

Funding